Folia Neuropathologica
eISSN: 1509-572x
ISSN: 1641-4640
Folia Neuropathologica
Current issue Archive Manuscripts accepted About the journal Special Issues Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
Search
Editorial Policies
Sarajevo Declaration on Integrity and Visibility of Scholarly Publications
2/2025
vol. 63
 
Share:
Send email
Share:
Original paper

Alzheimer’s disease-related a-synuclein gene expression in CA3 subfield of hippocampus in post-ischemic brain during 2-year survival

Ryszard Pluta
1
,
Anna Bogucka-Kocka
2
,
Jacek Bogucki
3
,
Janusz Kocki
4
,
Stanisław J. Czuczwar
1

  1. Department of Pathophysiology, Medical University of Lublin, Poland
  2. Chair and Department of Biology and Genetics, Medical University of Lublin, Poland
  3. Faculty of Medicine, John Paul II Catholic University of Lublin, Poland
  4. Department of Clinical Genetics, Medical University of Lublin, Poland
Folia Neuropathol 2025; 63 (2): 120-126
DOI: https://doi.org/10.5114/fn.2025.152012
Online publish date: 2025/07/04
Article file
- Alzheimer’s (1).pdf  [0.14 MB]
Get citation
 
PlumX metrics:
 
1. Chelluboina B, Kim T, Mehta SL, Kim JY, Bathula S, Vemuganti R.Impact of age and sex on a-syn (a-synuclein) knockdown-mediated poststroke recovery. Stroke 2020; 51: 3138-3141.
2. Colla E, Jensen PH, Pletnikova O, Troncoso JC, Glabe C, Lee MK. Accumulation of toxic alpha-synuclein oligomer within endoplasmic reticulum occurs in alpha-synucleinopathy in vivo. J Neurosci 2012; 32: 3301-3305.
3. Creed RB, Goldberg MS. Analysis of a-synuclein pathology in pink1 knockout rat brains. Front Neurosci 2019; 12: 1034.
4. Czuczwar SJ, Kocki J, Miziak B, Bogucki J, Bogucka-Kocka A, Pluta R. Alpha-, beta-, and gamma-secretase, amyloid precursor protein, and tau protein genes in the hippocampal CA3 subfield in an ischemic model of Alzheimer’s disease with survival up to 2 years. J Alzheimers Dis 2024; 98: 151-161.
5. Danzer KM, Haasen D, Karow AR, Moussaud S, Habeck M, Giese A, Kretzschmar H, Hengerer B, Kostka M. Different species of alpha-synuclein oligomers induce calcium influx and seeding. J Neurosci 2007; 27: 9220-9232.
6. Das TK, Ganesh BP, Fatima-Shad K. Common signaling pathways involved in Alzheimer’s disease and stroke: Two faces of the same coin. J Alzheimers Dis Rep 2023; 7: 381-398.
7. Devi L, Raghavendran V, Prabhu BM, Avadhani NG, Anandatheerthavarada HK. Mitochondrial import and accumulation of alpha-synuclein impair complex I in human dopaminergic neuronal cultures and Parkinson disease brain. J Biol Chem 2008; 283: 9089-9100.
8. Elman-Shina K, Efrati S. Ischemia as a common trigger for Alzheimer’s disease. Front Aging Neurosci 2022; 14: 1012779.
9. Eskandari S, Sajadimajd S, Alaei L, Soheilikhah Z, Derakhshankhah H, Bahrami G. Targeting common signaling pathways for the treatment of stroke and Alzheimer’s: a comprehensive review. Neurotox Res 2021; 39: 1589-1612.
10. Filler J, Georgakis MK, Dichgans M. Risk factors for cognitive impairment and dementia after stroke: a systematic review and meta-analysis. Lancet Healthy Longev 2024; 5: e31-e44.
11. Fisher RA, Miners JS, Love S. Pathological changes within the cerebral vasculature in Alzheimer’s disease: New perspectives. Brain Pathol 2022; 32: e13061.
12. Fırtına ÖB, Salt Ö, Sayhan MB, Dibirdik I, Yucal A. Value of plasma alpha- and beta-synuclein levels in the diagnosis, severity, and functional outcome of acute ischemic stroke. Turk J Emerg Med 2024; 24: 238-244.
13. Fujii H, Takahashi T, Mukai T, Tanaka S, Hosomi N, Maruyama H, Sakai N, Matsumoto M. Modifications of tau protein after cerebral ischemia and reperfusion in rats are similar to those occurring in Alzheimer’s disease – hyperphosphorylation and cleavage of 4- and 3-repeat tau. Br J Pharmacol 2016; 37: 2441-2457.
14. Hatsuta H, Takao M, Nogami A, Uchino A, Sumikura H, Takata T, Morimoto S, Kanemaru K, Adachi T, Arai T, Hasegawa M, Murayam S. Tau and TDP-43 accumulation of the basal nucleus of Meynert in individuals with cerebral lobar infarcts or hemorrhage. Acta Neuropathol Commun 2019; 7: 49.
15. Huang F, Liu Y, Wang Y, Xu J, Lian J, Zou Y, Wang C, Ding F, Wang Y. Co-aggregation of a-synuclein with amyloid-b stabilizes b-sheet-rich oligomers and enhances the formation of b-barrels. Phys Chem Chem Phys 2023; 25: 31604-316014.
16. Ishimaru H, Ueda K, Takahashi A, Maruyama Y. Changes in presynaptic protein NACP/alpha-synuclein in an ischemic gerbil hippocampus. Brain Res 1998; 788: 311-314.
17. Iwai A. Properties of NACP/alpha-synuclein and its role in Alzheimer’s disease. Biochim Biophys Acta 2000; 1502: 95-109.
18. Kato T, Hirano A, Katagiri T, Sasaki H, Yamada S. Neurofibrillary tangle formation in the nucleus basalis of Meynert ipsilateral to a massive cerebral infarct. Ann Neurol 1988; 23: 620-623.
19. Khan S, Yuldasheva NY, Batten TFC, Pickles AR, Kellett KAB, Saha S. Tau pathology and neurochemical changes associated with memory dysfunction in an optimized murine model of global cerebral ischaemia – A potential model for vascular dementia? Neurochem Int 2018; 118: 134-144.
20. Kim T, Mehta SL, Kaimal B, Lyons K, Dempsey RJ, Vemuganti R. Poststroke induction of alpha-synuclein mediates ischemic brain damage. J Neurosci 2016; 36: 7055-7065.
21. Kim T, Vemuganti R. Mechanisms of Parkinson’s disease-related proteins in mediating secondary brain damage after cerebral ischemia. J Cereb Blood Flow Metab 2017; 37: 1910-1926.
22. Kiryk A, Pluta R, Figiel I, Mikosz M, Ułamek M, Niewiadomska G, Jablonski M, Kaczmarek L. Transient brain ischemia due to cardiac arrest causes irreversible long-lasting cognitive injury. Behav Brain Res 2011; 219: 1-7.
23. Koh PO. Cerebral ischemic injury decreases a-synuclein expression in brain tissue and glutamate-exposed HT22 cells. Lab Anim Res 2017; 33: 244-250.
24. Kriska J, Hermanova Z, Knotek T, Tureckova J, Anderova M. On the common journey of neural cells through ischemic brain injury and Alzheimer’s disease. Int J Mol Sci 2021; 22: 9689.
25. Lecordier S, Pons V, Rivest S, ElAli A. Multifocal cerebral microinfarcts modulate early Alzheimer’s disease pathology in a sex-dependent manner. Front Immunol 2022; 12: 813536.
26. Liu X, Yao L, Ye X, Qin Y, Chen S, Jiang Q, Liu M, Chen X, Li W, Lin C, Zhu C, Zhao W, Wang Q. Danggui-Shaoyao-San (DSS) ameliorating cognitive impairment in ischemia-reperfusion vascular dementia mice through miR-124 regulating PI3K/Akt signaling pathway. Brain Res 2024; 1845: 149135.
27. Mehta SL, Kim T, Chelluboina B, Vemuganti R. Tau and GSK-3b are critical contributors to a-synuclein-mediated post-stroke brain damage. Neuromolecular Med 2023; 25: 94-101.
28. Pluta R, Ułamek M, Jabłoński M. Alzheimer’s mechanisms in ischemic brain degeneration. Anat Rec 2009; 292: 1863-1881.
29. Pluta R, Ułamek-Kozioł M, Kocki J, Bogucki J, Januszewski S, Bogucka-Kocka A, Czuczwar SJ. Expression of the tau protein and amyloid protein precursor processing genes in the CA3 area of the hippocampus in the ischemic model of Alzheimer’s disease in the rat. Mol Neurobiol 2020; 57: 1281-1290.
30. Pluta R. Brain ischemia as a bridge to Alzheimer’s disease. Neural Regen Res 2022; 17: 791-792.
31. Pluta R, Kiś J, Januszewski S, Jabłoński M, Czuczwar SJ. Cross-talk between amyloid, tau protein and free radicals in post-ischemic brain neurodegeneration in the form of Alzheimer’s disease proteinopathy. Antioxidants (Basel) 2022; 11: 146.
32. Pluta R, Kocki J, Bogucki J, Bogucka-Kocka A, Czuczwar SJ. LRP1 and RAGE genes transporting amyloid and tau protein in the hippocampal CA3 area in an ischemic model of Alzheimer’s disease with 2-year survival. Cells 2023; 12: 2763.
33. Pluta R, Miziak B, Czuczwar SJ. Post-ischemic permeability of the blood-brain barrier to amyloid and platelets as a factor in the maturation of Alzheimer’s disease-type brain neurodegeneration. Int J Mol Sci 2023; 24: 10739.
34. Pluta R, Bogucka-Kocka A, Bogucki J, Kocki J, Czuczwar SJ. Apoptosis, autophagy, and mitophagy genes in the CA3 area in an ischemic model of Alzheimer’s disease with 2-year survival. J Alzheimers Dis 2024; 99: 1375-1383.
35. Qi J, Wu H, Yang Y, Wang DD, Chen YX, Gu YH, Liu T. Cerebral ischemia and Alzheimer’s disease: The expression of amyloid and apolipoprotein E in human hippocampus. J Alzheimers Dis 2007; 12: 335-341.
36. Radenovic L, Nenadic M, Ułamek-Kozioł M, Januszewski S, Czuczwar SJ, Andjus PR, Pluta R. Heterogeneity in brain distribution of activated microglia and astrocytes in a rat ischemic model of Alzheimer’s disease after 2 years of survival. Aging (Albany NY) 2020; 12: 12251-12267.
37. Rost NS, Brodtmann A, Pase MP, van Veluw SJ, Biffi A, Duering M, Hinman JD, Dichgans M. Post-stroke cognitive impairment and dementia. Circ Res 2022; 130: 1252-1271.
38. Salminen A, Kauppinen A, Kaarniranta K. Hypoxia/ischemia activate processing of amyloid precursor protein: Impact of vascular dysfunction in the pathogenesis of Alzheimer’s disease. J Neurochem 2017; 140: 536-549.
39. Sekeljic V, Bataveljic D, Stamenkovic S, Ułamek M, Jabłoński M, Radenovic L, Pluta R, Andjus PR. Cellular markers of neuroinflammation and neurogenesis after ischemic brain injury in the long-term survival rat model. Brain Struct Funct 2012; 217: 411-420.
40. Shim KH, Kang MJ, Youn YC, An SSA, Kim S. Alpha-synuclein: a pathological factor with Ab and tau and biomarker in Alzheimer’s disease. Alzheimers Res Ther 2022; 14: 201.
41. Sweeney MD, Montagne A, Sagare AP, Nation DA, Schneider LS, Chui HC, Harrington MG, Pa J, Law M, Wang DJJ, Jacobs RE, Doubal FN, Ramirez J, Black SE, Nedergaard M, Benveniste H, Dichgans M, Iadecola C, Love S, Bath PM, Markus HS, Al-Shahi Salman R, Allan SM, Quinn TJ, Kalaria RN, Werring DJ, Carare RO, Touyz RM, Williams SCR, Moskowitz MA, Katusic ZS, Lutz SE, Lazarov O, Minshall RD, Rehman J, Davis TP, Wellington CL, González HM, Yuan C, Lockhart SN, Hughes TM, Chen CLH, Sachdev P, O’Brien JT, Skoog I, Pantoni L, Gustaf-son DR, Biessels GJ, Wallin A, Smith EE, Mok V, Wong A, Passmore P, Barkof F, Muller M, Breteler MMB, Román GC, Hamel E, Seshadri S, Gottesman RF, van Buchem MA, Arvanitakis Z, Schneider JA, Drewes LR, Hachinski V, Finch CE, Toga AW, Wardlaw JM, Zlokovic BV. Vascular dysfunction – The disregarded partner of Alzheimer’s disease. Alzheimers Dement 2019; 15: 158-167.
42. Twohig D, Nielsen HM. a-synuclein in the pathophysiology of Alzheimer’s disease. Mol Neurodegener 2019; 4: 23.
43. Ułamek-Kozioł M, Czuczwar SJ, Kocki J, Januszewski S, Bogucki J, Bogucka-Kocka A, Pluta R. Dysregulation of autophagy, mitophagy, and apoptosis genes in the CA3 region of the hippocampus in the ischemic model of Alzheimer’s disease in the rat. J Alzheimers Dis 2019; 72: 1279-1286.
44. Unal-Cevik I, Gursoy-Ozdemir Y, Yemisci M, Lule S, Gurer G, Can A, Müller V, Kahle PJ, Dalkara T. Alpha-synuclein aggregation induced by brief ischemia negatively impacts neuronal survival in vivo: a study in [A30P]alpha-synuclein transgenic mouse. J Cereb Blood Flow Metab 2011; 31: 913-923.
45. van Groen T, Puurunen K, Mäki HM, Sivenius J, Jolkkonen J. Transformation of diffuse b-amyloid precursor protein and b-amyloid deposits to plaques in the thalamus after transient occlusion of the middle cerebral artery in rats. Stroke 2005; 36: 1551-1556.
46. Wang C, Liu L, Zhang L, Peng Y, Zhou F. Redox reactions of the alpha-synuclein-Cu+ complex and their effects on neuronal cell viability. Biochemistry 2010; 49: 8134-8142.
47. Wen Y, Yang SH, Liu R, Perez EJ, Brun-Zinkernagel AM, Koulen P, Simpkins JW. Cdk5 is involved in NFT-like tauopathy induced by transient cerebral ischemia in female rats. Biochim Biophys Acta 2007; 1772: 473-483.
48. Wang Y, Li Y, Gu Y, Ma W, Guan Y, Guo M, Shao Q, Ji X, Liu J. Decreased levels of phosphorylated synuclein in plasma are correlated with poststroke cognitive impairment. Neural Regen Res 2025; 20: 2598-2610.
49. Wu YC, Bogale TA, Koistinaho J, Pizzi M, Rolova T, Bellucci A. The contribution of b-amyloid, Tau and a-synuclein to blood-brain barrier damage in neurodegenerative disorders. Acta Neuropathol 2024; 147: 39.
50. Wu Z, Li X, Zeng M, Qiu H, Feng H, Xu X, Yu S, Wu J. Alpha-synuclein alterations in red blood cells of peripheral blood after acute ischemic stroke. Int J Clin Exp Pathol 2019; 12: 1757-1763.
51. Yoon DK, Hwang IK, Yoo KY, Lee YB, Lee JJ, Kim JH, Kang TC, Lee BH, Sohn HS, Won MH. Comparison of alpha-synuclein immunoreactivity and protein levels in ischemic hippocampal CA1 region between adult and aged gerbils and correlation with Cu, Zn-superoxide dismutase. Neurosci Res 2006; 55: 434-441.
Copyright: © 2025 Mossakowski Medical Research Centre Polish Academy of Sciences and the Polish Association of Neuropathologists. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
  
Termedia
About us Contact
Copyright notice Privacy policy Advertising policy Contact us
Quick links
Journals Books eBooks Events
© 2025 Termedia Sp. z o.o.
Developed by Bentus.